Mortgage Blog

Why Pittsburgh biotech company Carmell Therapeutics is going public

It's the latest milestone for Carmell Therapeutics, which is based on the South Side at River Park Commons.

Previous Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
Next Study: Pregnant women with gestational diabetes, obesity more likely to have child with ADHD

Related Posts

Suggested Posts